GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Svas Biosana SpA (MIL:SVS) » Definitions » Beneish M-Score

Svas Biosana SpA (MIL:SVS) Beneish M-Score : -2.44 (As of Mar. 25, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Svas Biosana SpA Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.44 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Svas Biosana SpA's Beneish M-Score or its related term are showing as below:

MIL:SVS' s Beneish M-Score Range Over the Past 10 Years
Min: -2.9   Med: -2.42   Max: -2.21
Current: -2.44

During the past 6 years, the highest Beneish M-Score of Svas Biosana SpA was -2.21. The lowest was -2.90. And the median was -2.42.


Svas Biosana SpA Beneish M-Score Historical Data

The historical data trend for Svas Biosana SpA's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Svas Biosana SpA Beneish M-Score Chart

Svas Biosana SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -2.90 -2.39 -2.21 -2.44

Svas Biosana SpA Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -2.21 - -2.44 -

Competitive Comparison of Svas Biosana SpA's Beneish M-Score

For the Medical Devices subindustry, Svas Biosana SpA's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Svas Biosana SpA's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Svas Biosana SpA's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Svas Biosana SpA's Beneish M-Score falls into.



Svas Biosana SpA Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Svas Biosana SpA for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8273+0.528 * 1.0911+0.404 * 0.8588+0.892 * 1.2223+0.115 * 0.9785
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * 0.005012-0.327 * 1.0383
=-2.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €48.3 Mil.
Revenue was €121.6 Mil.
Gross Profit was €30.4 Mil.
Total Current Assets was €123.9 Mil.
Total Assets was €165.6 Mil.
Property, Plant and Equipment(Net PPE) was €26.8 Mil.
Depreciation, Depletion and Amortization(DDA) was €5.0 Mil.
Selling, General, & Admin. Expense(SGA) was €0.0 Mil.
Total Current Liabilities was €64.7 Mil.
Long-Term Debt & Capital Lease Obligation was €38.0 Mil.
Net Income was €5.1 Mil.
Gross Profit was €0.0 Mil.
Cash Flow from Operations was €4.3 Mil.
Total Receivables was €47.8 Mil.
Revenue was €99.5 Mil.
Gross Profit was €27.1 Mil.
Total Current Assets was €104.7 Mil.
Total Assets was €146.2 Mil.
Property, Plant and Equipment(Net PPE) was €26.2 Mil.
Depreciation, Depletion and Amortization(DDA) was €4.8 Mil.
Selling, General, & Admin. Expense(SGA) was €0.0 Mil.
Total Current Liabilities was €57.2 Mil.
Long-Term Debt & Capital Lease Obligation was €30.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(48.31 / 121.63) / (47.774 / 99.513)
=0.397188 / 0.480078
=0.8273

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(27.115 / 99.513) / (30.374 / 121.63)
=0.272477 / 0.249725
=1.0911

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (123.924 + 26.774) / 165.603) / (1 - (104.694 + 26.209) / 146.229)
=0.090004 / 0.104808
=0.8588

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=121.63 / 99.513
=1.2223

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.789 / (4.789 + 26.209)) / (5.02 / (5.02 + 26.774))
=0.154494 / 0.157891
=0.9785

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 121.63) / (0 / 99.513)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((38.039 + 64.676) / 165.603) / ((30.194 + 57.161) / 146.229)
=0.620248 / 0.597385
=1.0383

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(5.123 - 0 - 4.293) / 165.603
=0.005012

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Svas Biosana SpA has a M-score of -2.44 suggests that the company is unlikely to be a manipulator.


Svas Biosana SpA Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Svas Biosana SpA's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Svas Biosana SpA Business Description

Traded in Other Exchanges
N/A
Address
Via Trentola, 7, Somma Vesuviana, ITA
Svas Biosana SpA operates in the production and distribution of medical device.

Svas Biosana SpA Headlines

No Headlines